NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 20-F: Registration statement / Annual report / Transition report
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM): FY2022 Annual Report
20-F | NeuroSense Therapeutics Ltd. (0001875091) (Filer)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K/A: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 20-F: Registration statement / Annual report / Transition report
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
No Data